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1  | INTRODUC TION
In March 2002, an outbreak of low- pathogenic avian influenza 
(LPAI) A(H7N2) was detected among commercial poultry operations 
in Virginia. The Virginia Avian Influenza Task Force (VAITF) com-
posed of government workers was formed to detect and control 
the outbreak that lasted 4 months, infected 197 turkey and chicken 
flocks, and resulted in the depopulation of 4.7 million birds.1 North 
American LPAI H7N2 viruses circulated in live bird markets (LBM) of 
the northeastern United States from 1994 to 2006 and have been 
a source of infection for this and multiple commercial poultry out-
breaks.2-4 No human infections with LPAI H7N2 viruses had been 
documented prior to the 2002 Virginia outbreak. We describe a se-
rosurvey conducted among persons involved in control efforts that 
resulted in identification of the first human LPAI H7N2 infection.
2  | METHODS
We	performed	 a	 serosurvey	 among	 eligible	workers	 (≥18	years	 of	
age who had participated in control efforts of the LPAI H7N2 poultry 
outbreak in Virginia for at least 14 days by May 17, 2002) and who 
gave informed consent to enroll in the study. Outbreak- associated 
and previous exposure to wild birds and poultry, the use of personal 
protective equipment during control efforts, and recent ocular and 
respiratory symptoms were assessed. A blood sample was collected 
from each participant for serologic testing. A second blood sample 
was collected from participants whose first sample tested positive 
for antibody to influenza A(H7N2). The study was approved by the 
CDC’s institutional review board.
A LPAI A(H7N2) virus, A/Tky/VA/4529/2002 (Tky/VA), was iso-
lated from the respiratory tract of a turkey from the index farm in the 
poultry outbreak and was used for serologic testing of human serum 
samples. Each serum sample was tested at least twice in separate 
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Background: In March 2002, an outbreak of low- pathogenic avian influenza (LPAI) 
A(H7N2) was detected among commercial poultry operations in Virginia.
Methods: We performed a serosurvey of 80 government workers involved in efforts 
to control the outbreak.
Results: One study participant who assisted with disposal of infected birds tested 
positive for neutralizing antibodies to influenza A(H7N2) by microneutralization 
assay and H7- specific IgM antibodies by enzyme- linked immunosorbent assay 
(ELISA). The acute infection was temporally associated with an influenza- like illness 
that resolved without hospitalization.
Conclusion: This study documents the earliest evidence of human infection with an 
H7 influenza virus of the North American lineage.
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microneutralization (MN) assays for the presence of neutralizing 
antibodies to Tky/VA virus using a starting dilution of 1:20 as de-
scribed previously.5 Work with live Tky/VA virus was conducted in 
a biosafety level 3 laboratory with enhancements required by the 
US Department of Agriculture. Serum samples with duplicate titers 
of	≥80	were	 tested	 further	by	 immunoblot	and	an	enzyme-	linked	
immunosorbent assay (ELISA) detecting IgM also described previ-
ously,5 but using hemagglutinin protein derived from whole purified 
Tky/VA virus by treatment with bromelain.6 Additional testing was 
performed using adsorbed serum samples to rule out the possibility 
of antibody cross- reactivity between H7 and the A(H3N2) subtype. 
A contemporary human A(H3N2) virus was chosen for the adsorp-
tion protocol because the individual exhibited substantial titers to 
A(H3N2) virus (data not shown). In addition, H3 and H7 HA are both 
phylogenetic group 2 HA subtypes, raising the concern that cross- 
reactive antibody to the H3 HA could possibly interfere with the 
detection of authentic H7 subtype- specific antibodies.7 Briefly, a 
50 μL volume of serum was incubated with 100 μg of whole pu-
rified Tky/VA or purified A/Sydney/5/97 (H3N2) (Syd/97) viruses 
for 2.5 hours at 4°C followed by ultracentrifugation at 100 000 g 
for 30 minutes to remove virus- antibody complexes. Viral protein 
was measured by Bradford assay (Bio- Rad Laboratories, Hercules, 
CA, USA). To remove residual virus, sera were then adsorbed for 
30 minutes with a one- tenth volume of packed turkey red blood 
cells, followed by centrifugation at 21 000 g for 2 minutes at 4°C. 
Absorbed serum samples were tested by MN assay and ELISA using 
Tky/VA H7 HA and A/Panama/2007/99 (H3N2) (Pan/99) whole 
virus.
3  | RESULTS
Of the 80 persons completing testing, 63 (79%) were exposed to 
poultry or their contaminated environment; 17 (21%) had office du-
ties only. Exposure to potentially infected birds or virus- contaminated 
environments occurred through outbreak control activities including 
collection of swabs from dead birds and poultry facilities, disposal of 
dead birds, incineration of birds, disinfection of equipment, and labo-
ratory testing of poultry specimens. Many study participants (41%) 
reported >1 influenza- like illness (ILI) symptoms and 18% reported 
ocular symptoms during their deployment with VAITF. The use of 
personal protective equipment varied by activity (Table 1).
Serum from 1 study participant tested positive for antibody to 
Tky/VA virus, achieving titers of 1:80 by MN in several indepen-
dent assays (Table 2); sera from the remaining 79 participants tested 
seronegative. The specificity of the neutralizing antibody from the 
seropositive individual was determined by adsorption of sera with 
purified whole H7N2 and H3N2 viruses. Adsorption with H7N2, 
but not H3N2, removed the neutralizing antibody from the sera 
(Table 2). This result was confirmed by immunoblot analysis (data 
not shown), fulfilling WHO criteria for the serological identification 
of humans infected with avian influenza subtypes.8 This person (age 
mid- 20s) reported that he worked disposing of infected birds during 
the response and used gloves always and dust mask most of the time. 
Prior to outbreak, he had hunted waterfowl, but had limited expo-
sure to domestic poultry. He reported an illness with onset 10 days 
prior to study enrollment with feverishness, cough, sore throat, and 
headache. He sought medical care at a private facility 1 day after 
illness onset. Chest X- ray showed a right middle lobe infiltrate, and a 
diagnosis of lower respiratory tract infection was given. No diagnos-
tic specimens were collected for microbiologic testing. Outpatient 
treatment consisted of unspecified intramuscular and oral antibiot-
ics. He recovered fully.
TABLE  1 Characteristics of study participants, their exposures, 
use of personal protective equipment, and antibody test result
Characteristic Result
Age (n = 80, median) 45 (range 24- 70)
Days to serum collectiona (n = 80, median) 21 (range 14- 228b)
Control activities (n = 80)
 Touch birds (%) 52 (65)
 <1M from birds, no touching (%) 5 (6)
 Incineration, no touching (%) 6 (8)
 Office duties (%) 17 (21)
Influenza- like illness symptomsc (%)
 Feverishness (n = 80) 14 (18)
 T > 37.8°C (n = 80) 3 (4)
 Cough (n = 65) 20 (31)
 Sore throat (n = 65) 21 (32)
 Runny nose (n = 61) 13 (21)
 Headache (n = 61) 9 (15)
 Body ache (n = 61) 13 (21)
 Red or watery eyes (n = 61) 11 (18)
Use of personal protective equipment
 Gloves (always wore during activity) (%)
 Touched dead birds (n = 50) 44 (88)
 Touched infected birds (n = 32) 27 (84)
 Swabbed birds (n = 29) 26 (90)
 Collected environmental swabs (n = 14) 14 (100)
 Loaded culled birds on/off trucks (n = 39) 30 (77)
 Mask (always wore during activity) (%)
 Touched dead birds (n = 50) 14 (28)
 Touched infected birds (n = 32) 10 (31)
 Swabbed birds (n = 29) 6 (21)
 Collected environmental swabs (n = 14) 7 (50)
 Loaded culled birds on/off trucks (n = 39) 16 (41)
Antibodies to influenza A(H7N2) (n = 80) 1
aDays from first day of involvement in effort to control outbreak to day 
of serum collection. Range for seronegative persons (n = 79) was 
14- 70 d.
bSample collected on day 228 represents the second serum sample col-
lected from the H7 antibody- positive individual.
cDenominators vary because not all participants responded to each 
question.
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A second blood sample collected from the antibody- positive par-
ticipant 228 days after joining outbreak control efforts was also pos-
itive by MN for antibody to Tky/VA HA (Table 2). No banked serum 
collected before participation was available for comparison. The 2 
blood samples collected 21 days (10 days after symptom onset) and 
228 days after beginning work on outbreak control efforts were 
tested for IgM antibodies to Tky/VA HA by ELISA. (Table 2) IgM an-
tibody to Tky/VA HA was detected in the acute blood sample, but 
not in the convalescent blood sample. Adsorption of the acute blood 
sample with Tky/VA (H7), but not with Syd/97 (H3), removed the 
IgM antibody response suggesting that the antibody response was 
specific to Tky/VA (H7). Overall, these results suggest that a human 
infection with influenza A (H7) was temporally associated with a 
lower respiratory tract illness that occurred during participation in 
LP H7N2 avian influenza outbreak control efforts.
4  | DISCUSSION
While this investigation was carried out in 2002, this report provides 
evidence of risk of human infection with a North American line-
age LP H7N2 virus among persons exposed during control efforts. 
Exposure to and infection with an H7 influenza virus before partici-
pation in outbreak control efforts cannot be definitively excluded as 
no blood sample was available from the worker before engaging in 
VAITF activities. However, the presence of neutralizing antibodies 
and H7- specific IgM antibodies in the acute blood sample collected 
21 days after beginning disposal of infected carcasses and the ab-
sence of H7- specific IgM antibodies in a convalescent blood sample 
7 months later is consistent with an acute infection that likely oc-
curred through exposure during the outbreak. While other etiologies 
for the pneumonia cannot be excluded, the temporal association of 
the pneumonia with exposure to H7 outbreak viruses and serologic 
evidence of acute infection are consistent with a respiratory illness 
resulting from avian influenza A(H7N2) infection.
While the precise route of transmission is not known, the H7- 
infected worker had extensive exposure to infected birds during a 
21- day VAITF deployment through disposal activities that required 
a high level of direct contact with infected poultry. Current recom-
mendations by the Centers for Disease Control and Prevention and 
the US Department of Agriculture for the use of personal protective 
equipment recommendations for workers engaged in control efforts 
(made after the Virginia outbreak) include protective goggles and 
disposable particulate respirators, in addition to disposable gloves, 
coveralls, and shoe covers.9 While the worker reported always wear-
ing gloves, protective suit, and boots, he used a dust mask inconsis-
tently and never used eye protection.
Serologic testing of human sera for antibodies to H7 viruses had not 
been optimized or standardized, and no human positive controls were 
available for comparison at the time of this study, and the study protocol 
did not include collection of respiratory samples, and the H7 antibody- 
positive individual’s illness was not identified until after his enrollment. 
Without a pre- outbreak comparison of blood sample from this person, 
infection prior to working with the VAITF cannot be excluded; however, 
IgM results support our conclusions that this infection was associated 
with the VAITF deployment. Subsequent serologic investigations of a 
culture- confirmed A(H7N2) human infection in 2003 yielded a conva-
lescent neutralizing serum titer of 80, similar to the convalescent titer 
detected in the infected participant in the present study.10
The findings from this study further confirm that the North 
American lineage of LPAI A(H7N2) viruses that intermittently cause 
outbreaks among poultry can infect humans and cause respiratory 
illness; however, the overall risk of infection is low. While this study 
does not evaluate the effectiveness of personal protective equip-
ment, its consistent use by persons engaged in control efforts should 
be employed as part of efforts to reduce the risk of infection. During 
future outbreaks among poultry, persons assisting with depopula-
tion and surveillance of poultry, farmers, and poultry workers should 
be of high priority for illness monitoring and testing for infection 
with avian influenza viruses.
Adsorption treatment
Neutralizing antibody titer 
against Tk/VA/02 (H7N2) virusb
ELISA IgM titer againstc  
Tk/VA/02 (H7) HA
Sample 1 Sample 2 Sample 1 Sample 2
None 80 80 1600 100
RBC only 80 80 1600 100
Tk/VA/02 (H7N2) <20 <20 100 <100
Syd/97 (H3N2) 160 160 1600 100
ELISA, enzyme- linked immunosorbent assay.
aSerum samples were collected from the individual 21 d (Sample 1) and 228 d (Sample 2) after the 
first day of work with outbreak control operations.
bTiters represent the reciprocal of the highest dilution of serum exhibiting 50% neutralization of 100 
tissue culture infectious doses of virus. Untreated serum Sample 1 had a neutralizing antibody titer 
of 1:80 in 4 independent MN assays and was positive for antibody to purified Tk/VA/02 H7 HA by 
Western blot.
cSerum samples were diluted serially fourfold from a starting dilution of 1:100 in the first well. Titers 
represent the reciprocal of the highest dilution of the test serum achieving a value greater than the 
mean plus 3 standard deviations of 3- 6 negative controls at equivalent dilution.
TABLE  2 Serological response to 
H7N2 virus in antibody- positive study 
participant involved in outbreak control 
operationsa
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